Iniparib (BSI-201) | PARP inhibitor | Read Reviews & Product Citations Iniparib (BSI-201) is a potent PARP1 inhibitor with strong anti-neoplastic effect. Find all the information about Iniparib (BSI-201) for cell signaling research. ... Source Neuroscience 2010 171, 1256–1264. Iniparib (BSI-201) purchased from Selleck Method
Veliparib (ABT-888) | PARP inhibitor | Read Reviews & Product Citations Source Cancer Res 2011 71, 4944-4954. Veliparib (ABT-888) purchased from Selleck Method Clonogenic assays Cell Lines OVCAR-8 cells Concentrations 3 µmol/L Incubation Time 8 d Results Continuous exposure to either AZD2281 (olaparib) or ABT-888 ...
PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung canc 1. Carcinogenesis. 2013 Apr;34(4):739-49. doi: 10.1093/carcin/bgs393. Epub 2012 Dec 28. PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells. Cheng H, Zhang Z, Borczuk A, Powell CA, Balajee AS, Liebe
PARP1 - Wikipedia, the free encyclopedia Poly [ADP-ribose] polymerase 1 (PARP-1) also known as NAD+ ADP-ribosyltransferase 1 or poly[ADP-ribose] synthase 1 is an enzyme that in humans is encoded by the PARP1 gene.[1]
Cleaved PARP (Asp214) (D64E10) - Cell Signaling Technology Immunohistochemical analysis of paraffin-embedded human tonsil using Cleaved PARP (Asp214) ...
Cleaved PARP - Cell Signaling Technology 2013年2月22日 - human PARP, the cleavage occurs between Asp214 and. Gly215, which separates the ...
PARP (46D11) Rabbit mAb - Cell Signaling Technology 2014年3月21日 - Background: PARP, a 116 kDa nuclear poly (ADP-ribose) polymerase, appears to be ...
